Cargando…

Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital

BACKGROUND: With the increase of awareness of mycoplasma pneumoniae pneumonia (MPP), we found thrombosis in severe MPP (SMPP) was not rare. The aim of the study was to investigate the clinical characteristics, treatment, and long-term prognosis of MPP-associated thrombosis. METHODS: We retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinrong, He, Ruxuan, Wu, Runhui, Wang, Bei, Xu, Hui, Zhang, Yue, Li, Huimin, Zhao, Shunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966865/
https://www.ncbi.nlm.nih.gov/pubmed/31948402
http://dx.doi.org/10.1186/s12879-020-4774-9
_version_ 1783488833828945920
author Liu, Jinrong
He, Ruxuan
Wu, Runhui
Wang, Bei
Xu, Hui
Zhang, Yue
Li, Huimin
Zhao, Shunying
author_facet Liu, Jinrong
He, Ruxuan
Wu, Runhui
Wang, Bei
Xu, Hui
Zhang, Yue
Li, Huimin
Zhao, Shunying
author_sort Liu, Jinrong
collection PubMed
description BACKGROUND: With the increase of awareness of mycoplasma pneumoniae pneumonia (MPP), we found thrombosis in severe MPP (SMPP) was not rare. The aim of the study was to investigate the clinical characteristics, treatment, and long-term prognosis of MPP-associated thrombosis. METHODS: We retrospectively reviewed the medical records of 43 children with MPP-associated thrombosis between January 2013 and June 2019 at Beijing Children’s Hospital. The results of blood coagulation studies, autoimmune antibody, thrombophilia screening, contrast-enhanced lung computed tomography, echocardiography, and blood vessel ultrasonography were analyzed, as were treatment outcomes. RESULTS: Forty-two patients were diagnosed with SMPP. D-dimer was higher than 5.0 mg/L in 58.1% (25/43) of patients. The mean D-dimer level was 11.1 ± 12.4 mg/L. Anticardiolipin-IgM was positive in 60.0% of patients, β2-glycoprotein-IgM in 64.0%, and lupus anticoagulant in 42.1%. Chest imaging revealed pulmonary consolidation with lobe distribution in all patients (2/3–1 lobe in 10 patients, > 1 lobe in 29 patients). In our experience, thrombosis can occur in a vessel of any part of the body, and it can be initially detected as late as 31 days after disease onset. Thrombosis in the brain and abdomen can occur early, at 5 days after disease onset. Pulmonary vessels were the most commonly involved sites in the current study, and accordingly chest pain was the most common symptom (32.6%), followed by neurological symptoms (14.0%) and abdominal pain (9.3%). Thirty-five percent of patients were asymptomatic with regard to thrombosis. All patients underwent anticoagulant therapy, and thrombus absorption took > 3 months in most patients. All patients were followed until October 2019, at which time 41 were asymptomatic and 2 had mild recurrent cough. CONCLUSIONS: SMPP with pulmonary consolidation (> 2/3 lobe) was the most strongly associated risk factor for thrombosis. Thrombosis-associated symptoms may be subtle, even absent. Elevated D-dimer, specifically > 11.1 mg/L (even > 5.0 mg/L), would assist in the early diagnosis of thrombosis. The long-term prognosis of thrombosis was good after timely administration of anticoagulant therapy.
format Online
Article
Text
id pubmed-6966865
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69668652020-01-27 Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital Liu, Jinrong He, Ruxuan Wu, Runhui Wang, Bei Xu, Hui Zhang, Yue Li, Huimin Zhao, Shunying BMC Infect Dis Research Article BACKGROUND: With the increase of awareness of mycoplasma pneumoniae pneumonia (MPP), we found thrombosis in severe MPP (SMPP) was not rare. The aim of the study was to investigate the clinical characteristics, treatment, and long-term prognosis of MPP-associated thrombosis. METHODS: We retrospectively reviewed the medical records of 43 children with MPP-associated thrombosis between January 2013 and June 2019 at Beijing Children’s Hospital. The results of blood coagulation studies, autoimmune antibody, thrombophilia screening, contrast-enhanced lung computed tomography, echocardiography, and blood vessel ultrasonography were analyzed, as were treatment outcomes. RESULTS: Forty-two patients were diagnosed with SMPP. D-dimer was higher than 5.0 mg/L in 58.1% (25/43) of patients. The mean D-dimer level was 11.1 ± 12.4 mg/L. Anticardiolipin-IgM was positive in 60.0% of patients, β2-glycoprotein-IgM in 64.0%, and lupus anticoagulant in 42.1%. Chest imaging revealed pulmonary consolidation with lobe distribution in all patients (2/3–1 lobe in 10 patients, > 1 lobe in 29 patients). In our experience, thrombosis can occur in a vessel of any part of the body, and it can be initially detected as late as 31 days after disease onset. Thrombosis in the brain and abdomen can occur early, at 5 days after disease onset. Pulmonary vessels were the most commonly involved sites in the current study, and accordingly chest pain was the most common symptom (32.6%), followed by neurological symptoms (14.0%) and abdominal pain (9.3%). Thirty-five percent of patients were asymptomatic with regard to thrombosis. All patients underwent anticoagulant therapy, and thrombus absorption took > 3 months in most patients. All patients were followed until October 2019, at which time 41 were asymptomatic and 2 had mild recurrent cough. CONCLUSIONS: SMPP with pulmonary consolidation (> 2/3 lobe) was the most strongly associated risk factor for thrombosis. Thrombosis-associated symptoms may be subtle, even absent. Elevated D-dimer, specifically > 11.1 mg/L (even > 5.0 mg/L), would assist in the early diagnosis of thrombosis. The long-term prognosis of thrombosis was good after timely administration of anticoagulant therapy. BioMed Central 2020-01-16 /pmc/articles/PMC6966865/ /pubmed/31948402 http://dx.doi.org/10.1186/s12879-020-4774-9 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Liu, Jinrong
He, Ruxuan
Wu, Runhui
Wang, Bei
Xu, Hui
Zhang, Yue
Li, Huimin
Zhao, Shunying
Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
title Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
title_full Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
title_fullStr Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
title_full_unstemmed Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
title_short Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital
title_sort mycoplasma pneumoniae pneumonia associated thrombosis at beijing children’s hospital
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966865/
https://www.ncbi.nlm.nih.gov/pubmed/31948402
http://dx.doi.org/10.1186/s12879-020-4774-9
work_keys_str_mv AT liujinrong mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT heruxuan mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT wurunhui mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT wangbei mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT xuhui mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT zhangyue mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT lihuimin mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital
AT zhaoshunying mycoplasmapneumoniaepneumoniaassociatedthrombosisatbeijingchildrenshospital